Skip to content
‹ Back to IndustriesHealthcare

New York City digital health startups raised $1.9 billion in Q3, up 36%

New York City digital health startups raised $1.9 billion in Q3 2026, up 36% year over year. Nationally, Rock Health counted $3.7 billion raised by U.S. digital health startups across 114 deals in the quarter. Bigger checks and steady acquisitions mean buyers must assess which vendors are pulling ahead—and which may change owners mid-rollout.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · Digital HealthDigital Health New YorkRock HealthVenture Funding
Share
New York City digital health startups raised $1.9 billion in Q3, up 36%

Key takeaways

01

New York's digital health startups grew Q3 funding 36% year over year, while U.S. digital health startups raised $3.7 billion across 114 deals in Q3, according to Rock Health.

02

Average U.S. digital health deal size has climbed from $20.6 million in 2024 to $31.0 million so far in 2026, so more of the money is going into bigger rounds.

03

Acquisition is still how most digital health companies exit, with 164 deals through Q3 2026 and no new public listings since August 2025. That makes a vendor's change-of-ownership terms a live contract question for buyers.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

New York City's digital health startups raised $1.9 billion in the third quarter of 2026, according to a new report from Digital Health New York. That's 36% more than they raised in the same quarter of 2025. Crain's New York Business reporter Amanda D'Ambrosio broke the figures on October 29.

It's the second big quarter this year. On April 27, D'Ambrosio reported figures from Digital Health New York showing that the city's digital health startups brought in $1.6 billion in the first quarter. That total was up 60% from a year earlier and, according to the group, gave the sector its best first quarter since the pandemic. The Crain's headline described the $1.6B haul as a surge for digital health startups, with the money flowing to late-stage companies. The story's photo caption was plainer still: New York is outpacing the rest of the country in digital health investment growth.

For a health system CIO or a digital health procurement lead, the funding totals matter for one practical reason. They show which companies across the table have the money to support a multi-year rollout, and how likely those companies are to change owners before the rollout is done.

New York against the national count

Rock Health's national tally makes the city's pace stand out. The venture firm and advisory reported that U.S.-based digital health startups raised $3.7 billion across 114 deals in Q3 2026, bringing the year-to-date total to $11.1 billion across 358 deals.

The national quarter a year ago was only a little smaller. Healthcare Dive, reporting on Rock Health's Q3 2025 update, put that quarter at $3.5 billion across 107 deals. It also reported $9.9 billion raised through the third quarter of 2025, against $8.4 billion at the same point in 2024. So the national market is still growing, by $200 million in the quarter and $1.2 billion year to date. Next to New York's 36%, though, that looks like a gentle climb.

One caution before anyone puts the two numbers on the same slide. Digital Health New York and Rock Health run separate reports with their own definitions, so dividing the city's $1.9 billion by the national $3.7 billion doesn't give a reliable share.

Growth rates hold up better here than raw totals, because each report measures its quarter against its own year-earlier baseline. That makes the gap between New York's growth and the national change a reasonable directional signal, even if it isn't an exact one.

Digital health funding in 2026, city and nation

$1.6B
Raised by NYC startups in Q1 2026, up 60% year over year
$1.9B
Raised by NYC startups in Q3 2026, up 36% year over year
$11.1B
Raised by U.S. startups through Q3 2026, across 358 deals

Digital Health New York via Crain's New York Business; Rock Health

Bigger checks, fewer winners

The national money is gathering into larger rounds. Rock Health says capital keeps concentrating in bigger checks and fewer deals, and its average deal size so far in 2026 is $31.0 million, up from $29.5 million in 2025 and $20.6 million in 2024.

Those prior-year averages don't quite match the ones Rock Health published a year ago. In October 2025, Healthcare Dive reported the 2025 average at $28.1 million through the third quarter, against $20.4 million for 2024. If you're building a vendor-market slide, take the whole series from one edition rather than mixing editions.

Average U.S. digital health deal size ($M)
Rock Health · © MarketScaleDownload chart

The concentration already had a recognizable shape a year ago. Healthcare Dive's write-up of Rock Health's Q3 2025 data found startups signing fewer middle-stage deals and skipping series labels on their rounds. Meanwhile, rounds of $100 million or more kept increasing, often backed by large, well-known investors. The sector had logged 19 of those mega-rounds through the third quarter of 2025.

Rock Health says Q3 2026 continued the pattern from the year's earlier quarters: plenty of capital, much of it concentrated. For buyers, that changes how a funding headline should be read. A vendor that just closed a large round with a name-brand investor is probably in the group pulling ahead. A vendor without a recent labeled round may be in the thinning middle. Neither fact decides a purchase, but both say something about who will still be staffing implementation teams in two years.

Acquisitions, not listings, are the exit

Most of the change in ownership appears to be happening through M&A. Q3 2026 logged 45 digital health M&A deals, bringing the 2026 year-to-date total to 164, on par with 2025 (172 through Q3), according to Rock Health, which calls 2025 a high watermark since 2021. The public markets have stayed quiet, with no new listings since HeartFlow in August 2025.

Quiet hasn't meant silent. Rock Health flagged news of a postponed IPO, linking to Wall Street Journal coverage of Oura delaying its offering over market uncertainty. It also pointed to hints of debuts still to come, citing a report that Whoop's valuation had topped $10 billion. Until one of those listings clears, the M&A count is the more reliable guide to how funded vendors change hands.

That mix lands first on whoever owns vendor contracts at a health system. When acquisition is the usual way out, a well-funded startup bought this year could be one product line inside a larger company by next year. Its roadmap, support model and pricing could all change after the deal.

Before signing a multi-year digital health contract, ask the vendor in writing what happens to pricing, support commitments and access to your data if the company is acquired during the term.

Fifteen years of scale, and the consolidation that follows

Rock Health published its Q3 update on October 9, the week of its 15th annual Rock Health Summit, and used the anniversary to look back at where the sector started. In 2011, by its account, health systems and startups weren't often found in the same rooms. Patients getting care through consumer technology was still a distant bet.

Rock Health's report looks back on a sector that has raised more than $140 billion since 2011. Nearly half of American adults now own a wearable. The scale is real, and so is the consolidation that comes with it.

The report credits policy shifts with opening new paths to commercial success, and reimbursement codes with creating more reliable routes to recurring revenue. That history gives procurement teams one more question for any vendor on the shortlist: does its revenue rest on an established reimbursement route, or on something it still has to prove?

The next quarter to watch

For buyers, the next question is how many companies split New York's $1.9 billion. The answer would show whether the city's vendor pool is getting bigger or just richer.

Featured companies

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical agreed to acquire Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and the one-million-square-foot Medolla, Italy manufacturing campus for $125 million base plus up to $45 million tied to revenue and EBITDA milestones.
  • 02Rockwell said the combined business could generate $400-450 million in annual revenue, depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512